These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 7940194
1. Expression of p53 protein in gastric carcinomas is not independently prognostic. Motojima K, Furui J, Kohara N, Ito T, Kanematsu T. Surgery; 1994 Nov; 116(5):890-5. PubMed ID: 7940194 [Abstract] [Full Text] [Related]
2. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer. Ichiyoshi Y, Oiwa H, Tomisaki S, Sakaguchi Y, Ohno S, Maehara Y, Sugimachi K. Hepatogastroenterology; 1997 Nov; 44(14):546-53. PubMed ID: 9164535 [Abstract] [Full Text] [Related]
3. The clinical significance of p53 accumulation in gastric carcinoma. Starzynska T, Markiewski M, Domagala W, Marlicz K, Mietkiewski J, Roberts SA, Stern PL. Cancer; 1996 May 15; 77(10):2005-12. PubMed ID: 8640663 [Abstract] [Full Text] [Related]
4. Prognostic value of p53 protein expression for patients with gastric cancer--a multivariate analysis. Maehara Y, Tomoda M, Hasuda S, Kabashima A, Tokunaga E, Kakeji Y, Sugimachi K. Br J Cancer; 1999 Mar 15; 79(7-8):1255-61. PubMed ID: 10098768 [Abstract] [Full Text] [Related]
5. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer. Shun CT, Wu MS, Lin JT, Chen SY, Wang HP, Lee WJ, Wang TH, Chuang SM. Hepatogastroenterology; 1997 Mar 15; 44(14):604-9. PubMed ID: 9164544 [Abstract] [Full Text] [Related]
6. erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection. Motojima K, Furui J, Kohara N, Izawa K, Kanematsu T, Shiku H. Surgery; 1994 Mar 15; 115(3):349-54. PubMed ID: 7907434 [Abstract] [Full Text] [Related]
7. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas. Li X, Zheng H, Hara T, Takahashi H, Masuda S, Wang Z, Yang X, Guan Y, Takano Y. Int J Oncol; 2008 Jul 15; 33(1):69-79. PubMed ID: 18575752 [Abstract] [Full Text] [Related]
8. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Zheng HC, Takahashi H, Li XH, Hara T, Masuda S, Guan YF, Takano Y. Hum Pathol; 2008 Jul 15; 39(7):1042-9. PubMed ID: 18482745 [Abstract] [Full Text] [Related]
9. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features. Sheen-Chen SM, Chou CW, Chen MC, Chen FC, Chen YS, Chen JJ. Hepatogastroenterology; 1997 Jul 15; 44(17):1488-94. PubMed ID: 9356878 [Abstract] [Full Text] [Related]
10. Prognostic factors in early gastric cancer. Kunisaki C, Shimada H, Takahashi M, Ookubo K, Moriwaki Y, Akiyama H, Nomura M. Hepatogastroenterology; 2001 Jul 15; 48(37):294-8. PubMed ID: 11268989 [Abstract] [Full Text] [Related]
11. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma. Tomić S, Ilić Forko J, Babić D, Sundov D, Kuret S, Andelinović S. Croat Med J; 2003 Aug 15; 44(4):429-34. PubMed ID: 12950146 [Abstract] [Full Text] [Related]
12. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy. Díez M, Medrano MJ, Gutierrez A, López A, Mugüerza JM, Hernández P, Lozano O, Noguerales F, Ruíz A, Granell J. Anticancer Res; 2000 Aug 15; 20(5C):3929-33. PubMed ID: 11268479 [Abstract] [Full Text] [Related]
13. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma. Zheng HC, Zheng YS, Li XH, Takahashi H, Hara T, Masuda S, Yang XH, Guan YF, Takano Y. Anticancer Res; 2008 Aug 15; 28(4B):2225-32. PubMed ID: 18751399 [Abstract] [Full Text] [Related]
14. Decreased expression of p12 is associated with more advanced tumor invasion in human gastric cancer tissues. Choi MG, Sohn TS, Park SB, Paik YH, Noh JH, Kim KM, Park CK, Kim S. Eur Surg Res; 2009 Aug 15; 42(4):223-9. PubMed ID: 19279387 [Abstract] [Full Text] [Related]
15. Prognostic influence of p53 expression in gastric cancer. Müller W, Borchard F. J Pathol; 1996 Mar 15; 178(3):255-8. PubMed ID: 8778328 [Abstract] [Full Text] [Related]
16. Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer. Bani-Hani KE, Almasri NM, Khader YS, Sheyab FM, Karam HN. Clin Cancer Res; 2005 Feb 15; 11(4):1447-53. PubMed ID: 15746045 [Abstract] [Full Text] [Related]
17. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis. Dosaka-Akita H, Hu SX, Fujino M, Harada M, Kinoshita I, Xu HJ, Kuzumaki N, Kawakami Y, Benedict WF. Cancer; 1997 Apr 01; 79(7):1329-37. PubMed ID: 9083154 [Abstract] [Full Text] [Related]
18. Mutated p53 protein expression and proliferative activity in advanced gastric cancer. Ikeguchi M, Saito H, Kondo A, Tsujitani S, Maeta M, Kaibara N. Hepatogastroenterology; 1999 Apr 01; 46(28):2648-53. PubMed ID: 10522058 [Abstract] [Full Text] [Related]
19. Clinicopathological significance and survival influence of p53 protein expression in gastric carcinoma. Pinto-de-Sousa J, Silva F, David L, Leitão D, Seixas M, Pimenta A, Cardoso-de-Oliveira M. Histopathology; 2004 Apr 01; 44(4):323-31. PubMed ID: 15049897 [Abstract] [Full Text] [Related]
20. The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays. Li XH, Zheng HC, Wang ZG, Takahashi H, Yang XH, Guan YF, Takano Y. Anticancer Res; 2008 Apr 01; 28(2A):1061-7. PubMed ID: 18507055 [Abstract] [Full Text] [Related] Page: [Next] [New Search]